Abstract
to suggest a script for surgical oncology assistance in COVID-19 pandemic in Brazil. a narrative review and a "brainstorming" consensus were carried out after discussion with more than 350 Brazilian specialists and renowned surgeons from Portugal, France, Italy and United States of America. consensus on testing for COVID-19: 1- All patients to be operated should be tested between 24 and 48 before the procedure; 2- The team that has contact with sick or symptomatic patients should be tested; 3 - Chest tomography was suggested to investigate pulmonary changes. Consensus on protection of care teams: 1 - Use of surgical masks inside the hospitals. Use of N95 masks for all professionals in the operating room; 2 - Selection of cases for minimally invasive surgery and maximum pneumoperitoneal aspiration before removal of the surgical specimen; 2 - Optimization of the number of people in teams, with a minimum number of professionals, reducing their occupational exposure, the consumption of protective equipment and the circulation of people in the hospital environment; 3 - Isolation of contaminated patients. Priority consensus: 1- Construction of service priorities; 2 - Interdisciplinary discussion on minimally invasive or conventional pathways. the Brazilian Society of Surgical Oncology (BSSO) suggests a script for coping with oncological treatment, remembering that the impoundment in the assistance of these cases, can configure a new wave of overload in health systems.
Highlights
The estimate in Brazil for each year of the 2020-2022 triennium points out that there will be 625 thousand new cases of cancer (450 thousand when excluding cases of non-melanoma skin cancer)
A few and limited studies address the risk of COVID-19 in cancer patients undergoing treatment
Data are lacking to understand the dynamics of the disease and its spread in a country with peculiar characteristics like Brazil[2]
Summary
The estimate in Brazil for each year of the 2020-2022 triennium points out that there will be 625 thousand new cases of cancer (450 thousand when excluding cases of non-melanoma skin cancer). Non-melanoma skin cancer will be the most incident (177 thousand), followed by breast and prostate cancer (66 thousand each), colon and rectum (41 thousand), lung (30 thousand) and stomach (21 thousand). These data corroborate the magnitude of the problem[1,2]. A few and limited studies address the risk of COVID-19 in cancer patients undergoing treatment. The association of these diseases and its relations with our population are still poorly understood[2]. Data are lacking to understand the dynamics of the disease and its spread in a country with peculiar characteristics like Brazil[2]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
